Ironwood Pharmaceuticals Q1 Earnings Call Highlights

3 Stocks Trading Near $5 With Massive Earnings UpsideIronwood Pharmaceuticals (NASDAQ:IRWD) reported a strong start to 2026 and reiterated its full-year outlook, pointing to sharp first-quarter growth for LINZESS and continued progress toward a confirmatory phase III program for